dr. jen ashton joins us. >> good morning. >> why is it so much easier for the europeans to have stronger ingredients? >> look, this is a frustrating situation for the lay public and health professionals alike and it's really all about the process we undergo here for products to get fda approval. it's in place to assure the product, is it safe, is it effective? sometimes that process is better here, sometimes it's worse. it's definitely different. >> so what is it going to take for the fda to modify their regulations now? >> they have to test these products, and when you compare the products that we have here to what they have in europe, you know, europe's products tend to be more thorough, more complete, more broad spectrum. they cover both the uva and the uvb rays and they stay on our skin and have potential rally less absorption into our bloodstream but before we all pack up and move to europe to get these products, you know, it's interesting because if you look at the skin cancer statistics, bianna, in europe, let's say in a country like england, they haven't declined significantly si